Greenwich LifeSciences, Inc. Profile Avatar - Palmy Investing

Greenwich LifeSciences, Inc.

Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which h…

Biotechnology
US, Stafford [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Greenwich LifeSciences, Inc. (GLSI) to it's peer group.

Peer Group
AVXL AMLX NXTC XFOR DAWN VRPX RVPH EYEN TERN INZY PDSB ACXP MNOV ABOS Compare Together
Loading...
End of GLSI's Analysis
CIK: 1799788 CUSIP: 396879108 ISIN: US3968791083 LEI: - UEI: -
Secondary Listings
GLSI has no secondary listings inside our databases.